| Project/Area Number |
17K16474
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Radiation science
|
|---|
| Research Institution | Nara Medical University |
|---|
Principal Investigator |
Masada Tetsuya 奈良県立医科大学, 医学部, 助教 (60727593)
|
|---|
| Project Period (FY) |
2017-04-01 – 2019-03-31
|
| Project Status |
Completed (Fiscal Year 2018)
|
| Budget Amount *help |
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2018: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2017: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
|---|
| Keywords | VX2腫瘍 / TACE / リピオドール / エマルション / IVR / エマルジョン / 肝動脈化学塞栓術 / 肝細胞癌 / 医歯薬学 / 内科系臨床医学 / 放射線医学 / インターベンショナルラジオロジー（IVR) |
|---|
| Outline of Final Research Achievements |
In our in vivo study, histopathological findings of transarterial chemoembolization (TACE) using the pumping emulsification device were evaluated in a rabbit VX2 liver tumor model. As a result of our in vivo study, the pumping emulsification device can achieve stronger antitumor effects compared with the current standard technique using three-way cock.
|
| Academic Significance and Societal Importance of the Research Achievements |
肝細胞癌に対する肝動脈化学塞栓療法（TACE）における新規W/Oエマルションの作成を行った。抗腫瘍効果において従来法より効果的なエマルションの開発により、再発・進行肝細胞癌に対するTACEの治療成績向上に寄与することが期待できる。
|
